VolitionRX Ltd. (NYSE: VNRX) Starts Presentation at the 2017 Marcum Microcap Conference
VolitionRX (NYSE: VNRX) is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid -- an indication that disease is present. The company’s products aim to help to diagnose a range of cancers quickly, simply, accurately and cost effectively since early diagnosis often has the potential to prolong the life of patients. For more information, visit the company's website at www.volitionrx.com About NetworkNewsWire NetworkNewsWire (NNW)…







